Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles W Caldwell

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Epigenomics|January 11, 2012
Methylation of CD44 as a candidate biomarker in lymphomasGerald L Arthur, Charles W Caldwell
Epigenomics|January 11, 2012
DNA hypomethylation in a spectrum of plasma cell disordersGerald L Arthur, Charles W Caldwell
American Journal of Hematology|February 23, 2007
Refractory cytopenia with multilineage dysplasia and eosinophiliaAllison E Lisle, Charles W Caldwell
Epigenomics|November 30, 2011
Can promoter methylation in peripheral blood cells predict the development of cancer?Gerald L Arthur, Charles W Caldwell
Expert Review of Molecular Diagnostics|September 26, 2007
CpG islands: their potential as biomarkers for cancerHuidong Shi, Michael X Wang, Charles W Caldwell
Genes|April 9, 2014
Next generation sequencing: advances in characterizing the methylomeKristen H Taylor, Huidong Shi, Charles W Caldwell
Plos One|January 4, 2013
Pathway correlation profile of gene-gene co-expression for identifying pathway perturbationAllison N Tegge, Charles W Caldwell, Dong Xu
American Journal of Clinical Pathology|October 12, 2002
A decision-support system for flow cytometry immunophenotypingAdam L Asare, Jason S Ellis, Charles W Caldwell
Expert Review of Molecular Diagnostics|September 24, 2015
The potential of DNA modifications as biomarkers and therapeutic targets in oncologyAnna M Jankowska, Carl L Millward, Charles W Caldwell
Analytical Chemistry|November 17, 2009
Rapid and label-free detection of breast cancer biomarker CA15-3 in clinical human serum samples with optofluidic ring resonator sensorsHongying Zhu, Paul S Dale, Charles W Caldwell, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Epigenomics|January 11, 2012
Methylation of CD44 as a candidate biomarker in lymphomasGerald L Arthur, Charles W Caldwell
Epigenomics|January 11, 2012
DNA hypomethylation in a spectrum of plasma cell disordersGerald L Arthur, Charles W Caldwell
American Journal of Hematology|February 23, 2007
Refractory cytopenia with multilineage dysplasia and eosinophiliaAllison E Lisle, Charles W Caldwell
Epigenomics|November 30, 2011
Can promoter methylation in peripheral blood cells predict the development of cancer?Gerald L Arthur, Charles W Caldwell
Expert Review of Molecular Diagnostics|September 26, 2007
CpG islands: their potential as biomarkers for cancerHuidong Shi, Michael X Wang, Charles W Caldwell
Genes|April 9, 2014
Next generation sequencing: advances in characterizing the methylomeKristen H Taylor, Huidong Shi, Charles W Caldwell
Plos One|January 4, 2013
Pathway correlation profile of gene-gene co-expression for identifying pathway perturbationAllison N Tegge, Charles W Caldwell, Dong Xu
American Journal of Clinical Pathology|October 12, 2002
A decision-support system for flow cytometry immunophenotypingAdam L Asare, Jason S Ellis, Charles W Caldwell
Expert Review of Molecular Diagnostics|September 24, 2015
The potential of DNA modifications as biomarkers and therapeutic targets in oncologyAnna M Jankowska, Carl L Millward, Charles W Caldwell
Analytical Chemistry|November 17, 2009
Rapid and label-free detection of breast cancer biomarker CA15-3 in clinical human serum samples with optofluidic ring resonator sensorsHongying Zhu, Paul S Dale, Charles W Caldwell, et al.
Pageof 4